ADA: Tirzepatide Noninferior, Superior to Semaglutide for T2DM
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.